Glial fibrillary acidic protein in children with congenital heart disease undergoing cardiopulmonary bypass.

Abstract

OBJECTIVE To determine whether blood levels of the brain-specific biomarker glial fibrillary acidic protein rise during cardiopulmonary bypass for repair of congenital heart disease. METHODS This is a prospective observational pilot study to characterise the blood levels of glial fibrillary acidic protein during bypass. Children <21 years of age… (More)
DOI: 10.1017/S1047951113000851

Topics

Cite this paper

@article{Brunetti2014GlialFA, title={Glial fibrillary acidic protein in children with congenital heart disease undergoing cardiopulmonary bypass.}, author={Marissa A Brunetti and Jacky M. Jennings and R. Blaine Easley and Melania M Bembea and Anna Brown and Eugenie S Heitmiller and Jamie McElrath Schwartz and Ken M. Brady and Luca A. Vricella and Allen Dale Everett}, journal={Cardiology in the young}, year={2014}, volume={24 4}, pages={623-31} }